Acomplia diet drug

We have  good news for the drug company Sanofi Aventis that makes the weight loss medication Acomplia is that the EMEA which regulates drug sales and marketing for the European Union has allowed the company to mention the fact that Acomplia can help patients who have blood sugar problems in the form of diabetes.This was expected to happen since more and more patients reported excellent results in the test trials.

This means that from now on any Acomplia sold in the European Union will have a change on the labelling to inform patients and doctors of the positive effect that the drug can have on diabetes. At present the labeling of the Acomplia drug only mentioned that it is to be used with diet and exercise to help obese people lose weight or to help overweight people who have diabetes or other illnesses related to their weight.

Sanofi Aventis are very keen to get Acomplia known as a drug to treat diabetes and not just as a weight loss medication. This is extremely important to them because if the drug is prescribed as a diabetes medication it will be covered by most health insurance policies and this will mean that sales will rise. At present health insurance companies are not keen to reimburse patients for weight loss medication except in extreme circumstances.Early studies into Acomplia’s use to help quit smoking are encouraging, too. They suggest that Acomplia may double your chances of kicking the habit for good, without gaining excess weight (often a problem when people give up smoking).

Studies have reported an average weight loss of 10 per cent of bodyweight – with weight staying off, even up to two years later. Research has also revealed that most of the pounds are shed from the difficult to shift area around the waist.

Acomplia has also been shown to support cardiovascular health, improving cholesterol ratios and lowering triglyceride levels (bloodstream fats), and showing promise as an aid for diabetes and heart conditions.